Study details
Enrolling now
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
Southern California Institute for Research and Education
NCT IDNCT03073343ClinicalTrials.gov data as of Apr 2026
Target enrollment
48
Study length
about 12 years
Ages
18–75
Locations
1 site in CA
What this study is about
This trial is testing two different doses of oral betaine to see if it helps with liver problems. Patients will take the betaine as a powder mixed in water and drink it daily for 4431 days.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Betaine (trimethyglycine)
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Oral
How treatment is administered
Treatment Assignment
Randomized (Open Label)
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
betaine
Drug routes
oral (Oral Tablet)
Endpoints
Primary: Change in alanine aminotransferase (ALT) level in all study participants
Secondary: Compare changes in alanine aminotransferase (ALT) level in both cohorts
Body systems
Endocrinology